Simplicitybio: SimplicityBio joins 3.2M Eurostars funded Program
The HeartLinc Program led by FIRALIS aims to develop a test for the risk of developing heart failure after acute myocardial infarction. The availability of such a test would allow a more effective treatment and a drastic reduction of the burden of heart failure on healthcare systems.
Read full article »
SimplicityBio develops AI based analytics platform that develops multiomic signatures for drug discovery and biomarker identification.
Read more